Label Changes for:

Chantix (varenicline) tablets

December 2010

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – December 2010

 

ADVERSE REACTIONS

Postmarketing Experience
  • There have been reports of myocardial infarction (MI) and cerebrovascular accident (CVA) including ischemic and hemorrhagic events in patients taking Chantix

 

Hide
(web1)